Evidence map›Paper›PMID 34294940›Full record

ReviewPathologica2021

Mesenchymal tumours of the gastrointestinal tract.

Marta Sbaraglia, Gianluca Businello, Elena Bellan, Matteo Fassan, Angelo Paolo Dei Tos

Abstract readReview
In one paragraph

Review in Pathologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Surgical treatment of gastrointestinal stromal tumors.Journal of medicine and life · 2026
    Review
  6. NovelPathology oncology research : POR · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Effective Endoscopic Submucosal Dissection of a Huge Esophageal Liposarcoma: A Case Report.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marta SbaragliaDepartment of Pathology, Azienda Ospedale-Università Padova, Padua, Italy.
Gianluca BusinelloDepartment of Medicine, University of Padua School of Medicine, Padua, Italy.
Elena BellanDepartment of Medicine, University of Padua School of Medicine, Padua, Italy.
Matteo FassanDepartment of Pathology, Azienda Ospedale-Università Padova, Padua, Italy.
Angelo Paolo Dei TosDepartment of Pathology, Azienda Ospedale-Università Padova, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal tumours represent a heterogenous group of neoplasms encopassing benign, intermediate malignancy, and malignant entities. Sarcomas account for approximately 1% of human malignancies. In consideration of their rarity as well as of intrinsic complexity, diagnostic accuracy represents a major challenge. Traditionally, mesenchymal tumours are regarded as lesions the occurrence of which is mostly limited to somatic soft tissues. However, the occurrence of soft tissue tumours at visceral sites represent a well recognized event, and the GI-tract ranks among the most frequently involved visceral location. There exist entities such as gastrointestinal stromal tumours (GIST) and malignant gastointestinal neuroectodermal tumors that exhibit exquisite tropism for the GI-tract. This review will focus also on other relevant clinico-pathologic entities in which occurrence at visceral location is not at all negligible.

Indexed as

Gastrointestinal Stromal TumorsSarcomaSoft Tissue NeoplasmsHumansgastrointestinal tractGISTmesenchymal tumoursrare tumourssarcoma

Identifiers

PMID34294940
PMCPMC8299319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.